Literature DB >> 8101647

Shc products are substrates of erbB-2 kinase.

O Segatto1, G Pelicci, S Giuli, G Digiesi, P P Di Fiore, J McGlade, T Pawson, P G Pelicci.   

Abstract

The shc genes encodes three widely expressed proteins of 46, 52 and 66 kDa. Overexpression of p46shc and p52shc in NIH3T3 fibroblasts induces a tumorigenic phenotype. Shc products are phosphorylated on tyrosine by the activated epidermal growth factor receptor (EGFR) and become physically associated with EGFR via their SH2 domain. Thus Shc oncoproteins may play a role in mitogenic signal transduction. Here we report that Shc products are substrates also of the erbB-2 kinase and form complexes with the erbB-2 product in intact cells. In vitro, the bacterially expressed Shc SH2 domain is sufficient to reconstitute the high affinity Shc/erbB-2 interaction. The erbB-2 region required for Shc binding was narrowed down to the most COOH-terminal 179 residues of gp185erbB-2; within this region, phosphorylation of one or more of the erbB-2 autophosphorylation sites is required for Shc/gp185erbB-2 complex formation as well as optimal phosphorylation of Shc products by the erbB-2 kinase. Thus, Shc proteins may play a role in signal transduction by gp185erbB-2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101647

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation.

Authors:  D L Dankort; Z Wang; V Blackmore; M F Moran; W J Muller
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.

Authors:  N Altiok; S Altiok; J P Changeux
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.

Authors:  E Migliaccio; S Mele; A E Salcini; G Pelicci; K M Lai; G Superti-Furga; T Pawson; P P Di Fiore; L Lanfrancone; P G Pelicci
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

4.  Insulin induces tyrosine phosphorylation of Shc and stimulates Shc/GRB2 association in insulin-sensitive tissues of the intact rat.

Authors:  V Páez-Espinosa; C R Carvalho; F Alvarez-Rojas; L Janeri; L A Velloso; A C Boschero; M J Saad
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.633

5.  Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.

Authors:  S Giorgetti-Peraldi; E Ottinger; G Wolf; B Ye; T R Burke; S E Shoelson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

Authors:  R Pinkas-Kramarski; L Soussan; H Waterman; G Levkowitz; I Alroy; L Klapper; S Lavi; R Seger; B J Ratzkin; M Sela; Y Yarden
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

7.  Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.

Authors:  D Dankort; B Maslikowski; N Warner; N Kanno; H Kim; Z Wang; M F Moran; R G Oshima; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

8.  Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc.

Authors:  W Chen; J L Martindale; N J Holbrook; Y Liu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.

Authors:  A G Batzer; P Blaikie; K Nelson; J Schlessinger; B Margolis
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.